Medicare Enrolled

Dr. Pamela Kenyon, P.A.

Medical Physician Assistant · Miami, FL
Low-engagement
8940 N KENDALL DR, Miami, FL 33176
3055952141
In practice since 2005 (20 years)
NPI: 1609863679 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kenyon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kenyon? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kenyon

Dr. Pamela Kenyon is a medical physician assistant in Miami, FL, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Kenyon received a total of $10,821 from 69 pharmaceutical and/or device companies across 532 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kenyon is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $10,821 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$10,821
Total received (2021-2024)
Avg $2,705/year across 4 years
Top 3% in FL for medical physician assistant
69
Companies
532
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,821 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,832
2023
$3,516
2022
$2,429
2021
$2,044

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$863
Novartis Pharmaceuticals Corporation
$727
Celgene Corporation
$700
AstraZeneca Pharmaceuticals LP
$685
Janssen Biotech, Inc.
$536
Incyte Corporation
$528
PFIZER INC.
$436
Seagen Inc.
$429
Merck Sharp & Dohme LLC
$422
Lilly USA, LLC
$379
Daiichi Sankyo Inc.
$335
Astellas Pharma US Inc
$311
Eisai Inc.
$254
Genentech USA, Inc.
$253
Amgen Inc.
$235
Alexion Pharmaceuticals, Inc.
$202
Rigel Pharmaceuticals, Inc.
$196
GENZYME CORPORATION
$185
Takeda Pharmaceuticals U.S.A., Inc.
$181
ARRAY BIOPHARMA INC
$170
SOBI, INC
$168
Bayer Healthcare Pharmaceuticals Inc.
$139
Myriad Genetic Laboratories, Inc.
$137
Gilead Sciences, Inc.
$132
MorphoSys, US Inc.
$128
Bayer HealthCare Pharmaceuticals Inc.
$126
Pharmacyclics LLC, An AbbVie Company
$117
Regeneron Healthcare Solutions, Inc.
$107
Deciphera Pharmaceuticals Inc.
$103
Boehringer Ingelheim Pharmaceuticals, Inc.
$98
Dova Pharmaceuticals
$95
EMD Serono, Inc.
$82
Exelixis Inc.
$77
TerSera Therapeutics LLC
$74
Pharmacyclics LLC, an AbbVie Company
$70
Acrotech Biopharma Inc.
$64
Kyowa Kirin, Inc.
$64
BeiGene USA, Inc.
$63
Myovant Sciences Inc.
$60
Apellis Pharmaceuticals, Inc.
$58
Genmab U.S., Inc.
$47
Sumitomo Pharma America, Inc.
$47
PUMA BIOTECHNOLOGY, INC.
$45
Ipsen Biopharmaceuticals, Inc
$43
Sobi, Inc
$41
Pharmacosmos Therapeutics Inc.
$40
Karyopharm Therapeutics Inc.
$39
Epizyme, Inc.,
$39
Agios Pharmaceuticals, Inc.
$39
PharmaEssentia USA Corporation
$39
EUSA Pharma (US) LLC
$37
Mirati Therapeutics, Inc.
$36
G1 Therapeutics, Inc.
$33
GE HEALTHCARE
$25
Helsinn Therapeutics (U.S.), Inc.
$25
EISAI INC.
$24
Foundation Medicine, Inc.
$24
Aveo Pharmaceuticals, Inc.
$24
JAZZ PHARMACEUTICALS INC.
$22
Taiho Oncology, Inc.
$20
AVEO Pharmaceuticals, Inc.
$19
Alnylam Pharmaceuticals Inc.
$17
TAIHO ONCOLOGY, INC.
$17
ABBVIE INC.
$17
GlaxoSmithKline, LLC.
$16
TOLMAR Pharmaceuticals, Inc.
$16
Dendreon Pharmaceuticals LLC
$15
Blueprint Medicines Corporation
$14
Cumberland Pharmaceuticals, Inc.
$14
Top 3 companies account for 21.2% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · BAVENCIO · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · COSELA · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · ERLEADA · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nplate · Nubeqa · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · Stivarga · Sylvant · TAGRISSO · TAZVERIK · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · Ultomiris · VALCHLOR · VENCLEXTA · VERZENIO · VONJO · VONVENDI · Vectibix · Venclexta · XALKORI · XPOVIO · XTANDI · Xermelo · Xtandi · ZEPZELCA · Zoladex · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for medical physician assistant in FL.

Looking for a medical physician assistant in Miami?
Compare medical physician assistants in the Miami area by procedure volume, costs, and industry payment transparency.
Browse medical physician assistants nearby

Geographic Context

Medical physician assistants within 10 mi
348
Per 100K population
13.0
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kenyon is a medical physician assistant, with low-engagement industry engagement in the top 3% of FL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Kenyon receive payments from pharmaceutical companies?
Yes. Dr. Kenyon received a total of $10,821 from 69 companies across 532 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Kenyon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →